UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1-3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA

Hematological Oncology - United Kingdom
doi 10.1002/hon.169_2631